Abstract
Background
Calsequestrin-2 (CASQ2) is a Ca2+ buffering protein of myocardial sarcoplasmic reticulum. CASQ2 mutations underlie a form of catecholaminergic polymorphic ventricular tachycardia (CPVT). The CPVT phenotype is recapitulated in Casq2−/− mice. Repolarization lability (RL) - beat-to-beat variability in the T wave morphology - has been reported in long-QT syndrome, but has not been evaluated in CPVT.
Methods and Results
ECG from Casq2−/− mice was evaluated with respect to heart rate (HR) and RL changes prior to onset of ventricular tachycardia (VT) to gain insight into arrhythmogenesis in CPVT. Telemetry from unrestrained mice (3-month-old males, 5 animals of each genotype) and ECG before and after isoproterenol administration in anesthetized mice was analyzed. Average HR in sinus rhythm (SR), occurrence of non-sinus rhythm and RL were quantified. HR was slower in Casq2−/− animals. Accelerated junctional rhythm (JR) occurred more frequently in Casq2−/− mice and often preceded VT. In Casq2−/− mice, HR increased prior to VT onset, prior to onset of JR and on transition from JR to VT. RL increased during progression from SR to VT and after isoproterenol administration in Casq2−/−, but not in Casq2+/+ animals. Isoproterenol did not increase repolarization alternans in either genotype.
Conclusions
Accelerated JR, likely caused by triggered activity in His/Purkinje system, occurs frequently in Casq2−/− mice. Absence of CASQ2 results in increased RL. Increase in HR and in RL precede onset of arrhythmias in this CPVT model. Non-alternans RL precedes ventricular arrhythmia in wider range of conditions than previously appreciated.
Keywords: calsequestrin, catecholaminergic polymorphic ventricular tachycardia, junctional rhythm, repolarization lability, repolarization alternans, sudden death
Introduction
Calsequestrin (CASQ) is a Ca2+-binding protein present primarily in junctional sarcoplasmic reticulum of skeletal and cardiac muscle; the cardiac form (CASQ2) is encoded by a separate gene.1, 2 The primary role of CASQ2 is buffering of the sarcoplasmic reticulum Ca2+ ions, but another role for CASQ2 has emerged recently: CASQ2 regulates the open probability of ryanodine receptor 2 (RyR2).3, 4 Binding of Ca2+-free CASQ2 to the luminal side of RyR2 augments RyR2 inactivation and contributes to normal termination of calcium-induced calcium release. In the setting of sarcoplasmic reticulum Ca2+ overload, lower availability of Ca2+-free CASQ2 may result in spontaneous overload-induced calcium release, a potentially arrhythmogenic phenomenon.5
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a hereditary arrhythmic syndrome manifested by propensity to polymorphic or bidirectional ventricular tachycardia (VT) and risk of sudden cardiac death in the setting of β-adrenergic stimulation.6 The more common autosomal dominant form of the disease is usually caused by a mutation in RYR2.7, 8 The less common autosomal recessive form of CPVT is caused by CASQ2 mutations.9, 10 An abnormal sarcoplasmic reticulum Ca2+ release occurs in both CPVT forms; during diastole, activation of the electrogenic cardiac Na+/Ca2+ exchanger (NCX) tends to depolarize cell membrane and may result in triggered ectopic activity known as delayed after depolarization (DAD).
Casq2 has been knocked-out in the mouse to create a CPVT model. Casq2−/− animals exhibit the key features of the human disease: polymorphic or bidirectional VT during exercise or catecholamine administration, and structurally normal heart (though left ventricular hypertrophy is observed in aged animals).11 Although CPVT-related arrhythmias are associated with high sympathetic tone and preceded by sinus tachycardia during treadmill exercise, sinus bradycardia has been described in Casq2−/− mice.11, 12
CPVT is important both clinically and as a model of arrhythmias related to impaired Ca2+ handling. In contrast to other hereditary arrhythmias, such as long-QT syndrome (LQTS) or Brugada syndrome, no characteristic abnormality is usually present on resting ECG. Repolarization lability (RL) in the form of T wave alternans,13–15 QT interval variability16, 17 and non-alternans T-wave lability18–21 has been associated with propensity to ventricular arrhythmias in a wide variety of settings, but RL in CPVT or its animal models has not been well studied.
A large body of literature links T-wave alternans to ventricular arrhythmias and sudden cardiac death.22 Abnormal handling of intracellular Ca2+ seems to underlie T-wave alternans,23–25 but T-wave alternans is actually more difficult to induce in Langendorff-perfused hearts of Casq2−/− mice than in the wild-type animals.3
Non-alternans RL – i.e., beat-to-beat change in T wave morphology that does not follow an alternans pattern - has been described in patients with congenital LQTS18 and in a canine LQTS model.21 On a cellular level, non-alternans changes in action potential morphology occur in both canine and rabbit models of LQTS.21, 26 In another rabbit model of LQT2,19 non-alternans RL appears to be mechanistically related to secondary oscillations of calcium transient. These oscillations of calcium transient can eventually cause early after depolarizations, but precede the onset of ventricular ectopy. Although abnormal Ca2+ release from sarcoplasmic reticulum underlies arrhythmogenesis in CPVT, it is not known whether non-alternans RL occurs in CPVT models.
In this paper, we report data from a detailed evaluation of ECG recordings in Casq2−/− mice with respect to heart rate (HR), RL and rhythm changes prior to VT onset.
Methods
Studies were carried out according to NIH guidelines and approved by the Animal Care and Use Committees of Vanderbilt University. Casq2−/− mice were generated as described before.11 Ten male animals (5 Casq2−/−, 5 Casq2+/+) underwent ECG recording at 3 months of age. Surface ECG in anesthetized mice was recorded before and after application of i.p. isoproterenol at a dose of 1.5 mg/kg. ECG monitoring in 10 unrestrained mice (age, gender and genotype same as above) was performed as reported previously.11 The animals were allowed to recover for 72 hours after monitor implantation. Continuous ECG monitoring was performed during usual activity for 24 hours.
ECG analysis
ECG signal was sampled at 1 kHz (telemetry) or 2 kHz (isoproterenol experiments). The signals were analyzed off-line with software created in C++ Microsoft Visual Studio. After automatic detection of R wave peaks, the signal was low-pass filtered at 100 Hz using 3-pole Butterworth filter. Smooth cubic spline (passing through fiducial points preceding R wave by 10 ms) was subtracted to minimize baseline fluctuation. All recordings were manually reviewed; poor-quality data segments were excluded. During each 1 hour data segments, several ECG features were analyzed:
presence of rhythm distinct from sinus rhythm (SR)
average HR (expressed as average RR interval during SR) and total HR variability (standard deviation of normal RR intervals; SDNN)
-
if present, an example of each of the following events was tagged in each 1 hour ECG segment:
“stable SR”: SR preceded and followed by at least 300 s of continuous SR
“VT or complex ventricular ectopy”: either VT of > 3 beats duration or frequent ventricular ectopy (bigeminy, trigeminy) of at least 2 s duration
“junctional rhythm”: at least 60 beat segment of continuous JR, terminating with SR
“pre-junctional SR”: 60 beat SR immediately preceding JR
“pre-VT SR”: 60 beat SR segment immediately preceding a segment of VT or complex ventricular ectopy (without intervening JR)
“pre-VT junctional rhythm”: 60 beat JR segment immediately preceding VT or complex ventricular ectopy
For the tagged rhythm episodes listed above, 60 consecutive beats were analyzed with respect to the following:
average HR (average RR interval) and short-term HR variability (root-mean- square of successive RR interval differences; RMSSD)
signal-averaged tracing and the corresponding signal lability were evaluated in a similar way as described before.18, 19 Briefly, for each time-point in the cardiac cycle, ECG signal lability was defined as root-mean-square (RMS) of beat-to-beat amplitude differences at a given time with respect to R wave peak. This was only calculated when the 60 consecutive beats were of SR or JR, without intervening ventricular ectopy.
average value of signal lability (defined above) was calculated during early repolarization window (30 to 35 ms after R wave peak) and normalized for amplitude (maximal value minus minimal value) of the signal-averaged QRS complex. After logarithmic transformation, this value was called “repolarization lability”, or RL. See Fig. 1 and its legend for more details.
alternans component of RL was quantified as RMS of signal-averaged difference between the odd and even beats in the early repolarization window. After normalization for QRS amplitude and logarithmic transformation, this value was called “repolarization alternans”
duration of the QRSJ complex, defined as the time interval from the R wave peak to the moment when the signal-averaged ECG signal drops under 5% of the QRS complex amplitude. In mice, ventricular repolarization starts before completion of ventricular depolarization. The terminal portion of the high-frequency deflection, which would be classified as end of QRS in humans, actually corresponds to beginning of repolarization. The closest human equivalent is the J wave. For this reason, we use the term “QRSJ complex duration” for this variable.
Fig. 1.
The algorithm for calculation of repolarization lability (RL) is illustrated. A Sixty consecutive QRST complexes are aligned along the R wave peak. For clarity, only 5 color-coded complexes are shown and signal lability is exaggerated. At each time (t) in a portion of the cardiac cycle, the sequence of 60 signal amplitudes is used to calculate signal lability. B Signal lability is calculated from differences between amplitudes of consecutive QRST complexes (Δ1, Δ2, …, Δ59) at time t. Only Δ1 and Δ59 are shown for clarity. Color-coding is consistent with panel A. C Lability of the ECG signal at time t is calculated as root-mean-square of Δ1, …, Δ59, i.e. as the square root of the average of the squared differences at time t. The signal lability values are plotted as the green curves in Fig. 3 and Fig. 5. Average signal lability in the early repolarization window (i.e. t ranging from 30 ms to 35 ms after R wave peak) is normalized for amplitude of QRS complex (QRSmax−QRSmin) and RL is calculated as the natural logarithm of the value. It is a measure of short-term beat-to-beat repolarization signal variability which includes, but is not limited to, repolarization alternans. It is closely related to the measures of T-wave lability reported in references 18 and 19.
ECG signal quality in each of the 60-beat data segment was quantified using the following parameters:
high-frequency noise: high-frequency signal was defined as the difference between the raw and low-pass filtered signal. The RMS of the high-frequency signal was calculated from the 60 consecutive beats at each point in the window ranging from 35 to 80 ms after R wave peak and normalized for QRS complex amplitude. The maximal value in this interval was used as a measure of high-frequency noise, such as skeletal myopotentials.
baseline fluctuation: this was calculated as RMS of differences between amplitudes of subsequent fiducial points (after low-pass filtering, before baseline subtraction), normalized for QRS amplitude. Since spline subtraction is an imperfect way to remove baseline fluctuations, high values signify residual signal contamination with low-frequency noise
QRS lability: defined as RMS of beat-to-beat values of the signal at the time of maximal value of signal-averaged QRS, normalized for QRS amplitude. High values are associated with beat-to-beat changes in QRS morphology, expected during changes in animal posture and resulting changes of cardiac axis with respect to the vector of ECG lead
Elevation of any of these parameters indicates decreased signal quality.
Statistical analysis
Frequency of categorical variables was compared using Fisher exact test (VassarStats; faculty.vassar.edu/lowry/VassarStats.html). The rest of the statistical analysis was performed in Microsoft Excel 2007. Variables obtained from Casq2+/+ and Casq2−/− animals were compared using unpaired t-test. Variables from the same animals during different rhythm episodes were compared using paired t-test; only those 1 hour segments which contained both rhythms of interest were evaluated. All reported p-values are two-tailed. P-values <0.05 were considered significant.
Results
Heart rhythm
VT episodes, frequently of bidirectional morphology, occurred in all Casq2−/− (133±118 episodes over 24 hours), but in none of the Casq2+/+ mice. Episodes of accelerated JR occurred in both Casq2−/− and Casq2+/+ animals, but were markedly more frequent in the former: accelerated JR was present in 93 out of 120 one-hour long data segments in the Casq2−/−, and in 26 out of 120 segments in the Casq2+/+ animals (p<0.0001; Fig. 2A,B). VT was preceded by JR rather than sinus rhythm (Fig. 2C) in 436 out of 664 (65.7%) episodes; most JR episodes did not escalate to VT.
Fig. 2.
Examples of ECG signal from unrestrained mice. Each panel shows a continuous recording. Duration of RR intervals in ms is indicated in red. Time from the beginning of the file is displayed at the beginning of each rhythm strip in hh:mm:ss format. A Sinus rhythm in a Casq2+/+ animal. B Transition from SR to JR in a Casq2−/− animal. C JR precedes onset of bidirectional ventricular tachycardia in a Casq2−/− animal. Note the slower SR in Casq2−/− animal in panel B compared to Casq2+/+ in panel A, and the slight increase in HR during transition from SR to JR in B.
Heart rate
Average RR interval during 24 hour monitoring period during SR was longer in the Casq2−/− than in the Casq2+/+ mice (130±10 vs. 111±5 ms; p<0.005), indicating slower HR in Casq2−/− mice.a Total HR variability (SDNN) did not differ between genotypes (11±4 vs. 12±2 ms; NS).
In the Casq2−/− animals, RR interval was longer during stable SR than during SR preceding onset of accelerated JR (140±14 vs. 131±15 ms; p<0.0001) and during stable SR compared to SR preceding VT or complex ventricular ectopy onset (128±8 vs. 115±8 ms; p<0.0001). RR interval during JR was shorter than during the preceding SR (115±8 ms vs. 131±15; p<0.0001) and further decreased prior to VT or complex ventricular ectopy onset (115±7 vs. 110±6 ms; p<0.0001). Short-term HR variability (RMSSD) did not change during any of these rhythm transitions.
Repolarization lability in Casq2−/− mice
During SR, RL increased before the onset of accelerated JR, as compared to stable SR (−3.73±0.62 vs. −4.24±0.78; p<0.0005).b Compared to stable SR, RL was also elevated during SR prior to onset of VT or complex ventricular ectopy (−3.09±0.37 vs. −4.38±0.37; p<0.0001). During JR, RL was higher than during the preceding SR (−3.08±0.42 vs. −3.761±0.60; p<0.0001) and increased again prior to VT or complex ventricular ectopy onset (−3.18±0.39 vs. −2.98±0.39; p<0.005; Fig. 3). These transitions were accompanied by an increase in at least one ECG noise index (Table I).
Fig. 3.
Signal-averaged ECG (red) and signal lability (green) calculated from 60 consecutive beats from a Casq2−/− animal during stable SR (A) and SR preceding VT onset (B). The Y-axis of the lability signal is magnified 10-fold with respect to the signal-averaged ECG. The blue horizontal bars indicate 25 ms time interval. The parallel vertical bars mark the window used for RL calculation. The horizontal arrows denote QRSJ complex duration. RL and QRSJ complex duration both increase before VT onset.
Table I.
Values of ECG noise indices in Casq2−/− mice during telemetry and isoproterenol experiments. In the telemetry data, at least one of the indices increases when the rhythm progresses from stable SR to pre-VT rhythm. No decline in ECG quality is observed after isoproterenol administration.
| QRS lability | Baseline lability | HF noise | |
|---|---|---|---|
| stable SR vs. pre-junctional SR | 0.038±0.017 vs. 0.065±0.037 † | 0.012±0.005 vs. 0.021±0.012 † | 0.007±0.005 vs. 0.014±0.007 † |
| stable SR vs. pre-VT SR | 0.037±0.016 vs. 0.084±0.028 † | 0.010±0.004 vs. 0.029±0.010 † | 0.005±0.008 vs. 0.019±0.017 † |
| Pre-junctional SR vs. junctional rhythm | 0.066±0.037 vs. 0.084±0.029 † | 0.020±0.012 vs. 0.034±0.014 † | 0.014±0.007 vs. 0.018±0.009 * |
| Junctional rhythm vs. junctional rhythm pre-VT | 0.077±0.025 vs. 0.088±0.031 * | 0.031±0.013 vs. 0.033±0.012 NS | 0.018±0.009 vs. 0.021±0.010 NS |
| SR before isoproterenol vs. SR after isoproterenol | 0.048±0.020 vs. 0.068±0.025 NS | 0.029±0.012 vs. 0.038±0.011 NS | 0.024±0.009 vs. 0.024±0.011 NS |
p<0.05
p<0.0001
Repolarization morphology
In addition to accelerated junctional rhythm, another unexpected phenomenon was noted prior to VT or complex ventricular ectopy onset in Casq2−/− mice, namely a gradual change in the morphology of late high-frequency deflection (Fig. 3). The high-frequency deflection reflects both depolarization and early repolarization in mice. As detailed in Methods, we used duration of the QRSJ complex to quantify this change in morphology of early repolarization. QRSJ complex duration did not differ between stable SR and SR preceding JR (19±4 vs. 20±5 ms; NS), but it did increase during SR preceding VT or complex ventricular ectopy (18±3 vs. 24±4 ms; p<0.0001). QRSJ complex duration during JR was longer than during the preceding SR (23±5 vs. 20±4 ms; p<0.0001) and additional prolongation occurred prior to VT or complex ventricular ectopy onset (23±5 vs. 27±5 ms; p<0.0001).
Isoproterenol effect
Before isoproterenol administration, RR interval was longer (i.e., HR was slower) in Casq2−/− than in Casq2+/+ animals (147±12 vs. 122±5 ms; p< 0.01). After isoproterenol, RR interval was similar in both genotypes (108±4 vs. 108±7 ms; NS). RR interval decrease following isoproterenol was significant in both genotypes (Fig. 4A).
Fig. 4.
Comparisons of mean RR interval (A), RL (B) and QRSJ complex duration (C) in Casq2−/− animals (KO) before and after isoproterenol, and between Casq2+/+ (WT) and Casq2−/− after isoproterenol. The black symbols (‡ <0.01; § <0.05) indicate difference between values measured before and after isoproterenol. White symbols (* <0.01; # <0.05) signify differences between values obtained from Casq2+/+ and Casq2−/− animals. RL and QRSJ complex duration all increase after isoproterenol in Casq2−/− animals, and are higher in Casq2−/− than Casq2+/+ animals after isoproterenol.
Isoproterenol increased RL in Casq2−/− (−3.41±0.33 vs. −3.05±0.52; p<0.05), but not in Casq2+/+ animals (−4.23±0.53 vs. −4.12±0.38; NS; Fig. 4B, Fig. 5). RL in SR was higher in Casq2−/− than in Casq2+/+ mice before (−3.41±0.33 vs. −4.12±0.38; p<0.02) and after isoproterenol (−3.05±0.52 vs. −4.23±0.53; p<0.01; Fig. 4B). RL change after isoproterenol was significant in Casq2−/− (p<0.05), but not in Casq2+/+ animals. Interestingly, repolarization alternans did not change significantly after isoproterenol in either genotype (Casq2−/−: −5.87±0.72 vs. −5.72±0.88; Casq2+/+ : −5.26±0.95 vs. −6.80±0.85) and did not differ between the two genotypes.
Fig. 5.
Examples of signal-averaged ECG and signal lability in a Casq2−/− (A) and Casq2+/+ (B) animal before (left) and after (right) isoproterenol. The meaning of the symbols is same as in Fig. 3. After isoproterenol, RL and QRSJ complex duration increase in Casq2−/− animal, but change minimally in Casq2+/+.
QRSJ complex duration in SR was similar in Casq2−/− and Casq2+/+ mice at baseline (16±1 vs. 15±1 ms; NS), but became significantly longer in Casq2−/− after isoproterenol (24±3 vs. 16±2 ms; p<0.005; Fig. 4C). There was no significant change in QRSJ complex duration after isoproterenol administration in Casq2+/+, although a significant increase (p<0.01) occurred in Casq2−/− mice.
None of the 3 indices of ECG signal noise increased in SR after isoproterenol administration compared to baseline in animals of either genotype (Table I).
Discussion
We describe novel ECG phenomena preceding VT onset in the Casq2−/− animals: frequent episodes of accelerated JR, changes in QRSJ complex morphology, and increase in HR and RL, though not of repolarization alternans. These dynamic ECG changes occur both during spontaneous activity in unrestrained mice and after isoproterenol administration. They link the underlying molecular abnormality to mechanism of arrhythmogenesis on the animal level. Presence of sinus bradycardia reported previously in unrestrained Casq2−/− animals was confirmed.
Sinus bradycardia
Abnormally slow sinus rate has been reported in mice lacking CASQ2 before.11, 12 Sinus bradycardia also occurs in CPVT.6, 9 It remains uncertain how the sinus node dysfunction relates to the Ca2+ handling abnormality. Nevertheless, spontaneous Ca2+ release from SR stores is important for normal sinus node automaticity. According to the “calcium clock” theory,27 gradual Ca2+ accumulation in sarcoplasmic reticulum of SAN cells eventually results in spontaneous Ca2+ release and contributes to diastolic depolarization through NCX activation. Absence of CASQ2 is known to increase frequency of Ca2+ sparks in isolated ventricular myocytes.28, 29 Therefore, acceleration rather than delay of the “calcium clock” might be expected. However, the Casq2−/− mice have lower sarcoplasmic reticulum Ca2+ content than the wild-type animals;11 it is possible that in the absence of β-adrenergic stimulation, the amplitude of Ca2+ release in SAN cells in Casq2−/− animals is too small to promote automaticity. Moreover, augmentation of CaMKII activity by oxidation has been shown to result in apoptosis of SAN cells and SAN dysfunction.30 Conceivably, chronic Ca2+ leakage in Casq2−/− mice may have a similar effect on CaMKII activity. Regardless of the mechanism, sinus bradycardia caused by CASQ2 absence attests to the importance of this protein in normal SAN automaticity.
Accelerated junctional rhythm
Accelerated JR in Casq2−/− mice has not been reported before to the best of our knowledge. A report on mice with Casq2 deletion by another group does mention a presence of JR in an anesthetized animal, but this was interpreted as a junctional escape rhythm.12 The data reported here establish that JR is markedly more common in Casq2−/− animals. This is best understood as accelerated JR rather than escape rhythm during especially profound episodes of sinus bradycardia: HR during SR actually increases before JR onset, and increases again during transition from SR to JR. Average RR interval during JR is shorter than during SR, and comparable to average RR interval during SR in Casq2+/+ animals. It is likely that accelerated JR in Casq2−/− mice is a manifestation of triggered activity in the His/Purkinje tissue. Interestingly, Purkinje fibers appear to be more prone to triggered activity than working ventricular myocardium in another CPVT model involving Ryr2 mutation.31 If the level of β-adrenergic stimulation required to elicit triggered activity is lower in His/Purkinje tissue than in working ventricular myocardium of Casq2−/− mice, the observed pattern of JR episodes, which frequently precede VT episodes, but also occur without VT, would not be surprising. We are not aware of any reports describing accelerated JR in CPVT patients. However, JR occurs in digitalis toxicity, a condition which, like CPVT, is characterized by DADs.
Repolarization lability and ECG morphology changes
RL in the form of T-wave alternans, non-alternans T wave lability and QT interval variability has been associated with clinical arrhythmias in humans and animal models. However, arrhythmias in CPVT are believed to arise as a consequence of DADs, which occur after repolarization is completed. Nevertheless, repolarization abnormality has been reported in CPVT patients: Viitisalo et al.32 described dynamic T wave splitting in CPVT subjects, and Nof et al.33 found a marked QT prolongation and T wave changes after a post-pacing pause in a CPVT kindred with RYR2 mutation. Thus, the Ca2+ handling abnormality underlying CPVT can affect electrical systole.
We had some concern regarding the interpretation of increased RL prior to JR and VT in the telemetry data: if the episodes of spontaneous JR and VT are triggered by increased physical activity, the analysis could be biased by increased ECG noise due to skeletal myopotentials and changes of the cardiac axis as the animal changes position. The increase in noise level does indeed occur prior to JR and VT (Table I). However, we believe that the increase in RL is not solely attributable to increased noise, for 2 reasons:
1/ in several cases (e.g. Fig. 3B), we observed a distinct peak of ECG lability as the ECG signal returns to baseline at the end of QRSJ complex; this would be difficult to explain by the nonspecific effects discussed above
2/ more importantly, no increase in noise prior to VT onset was observed in the experiments involving isoproterenol administration to anesthetized animals. Nevertheless, RL increase was still present under these conditions.
Moreover, increased RL was accompanied by a characteristic change in QRSJ complex morphology (Fig. 3, Fig. 5A). The QRSJ complex duration assessed in the present paper is similar to the Qb interval described by Danik et al.34 In that report, this interval corresponded approximately to 50% repolarization (APD50) on monophasic action potential recording. Thus, the QRSJ complex changes we observed likely reflect increased voltage gradients in ventricular tissue during early repolarization phase.
The cellular mechanism underlying increased RL and altered early repolarization morphology remains uncertain, but likely involves altered Ca2+ handling. It is possible that in the setting of β-adrenergic stimulation and increased Ca2+ loading of sarcoplasmic reticulum, spontaneous (i.e., not triggered by L-type Ca channel opening) Ca2+ release occurs relatively early after AP upstroke – before AP termination – in Casq2−/− animals. This would activate NCX and prolong phase 3 of AP in spatially heterogeneous manner, leading to steeper voltage gradients and prolonged QRSJ complex duration. If there is a stochastic component to the spontaneous Ca2+ release on the cellular level, it could manifest as beat-to-beat variability of action potential course and, on the animal level, as RL. This mechanism does appear to operate in LQTS.19
Of note, tachycardia-induced repolarization alternans is actually more difficult to induce in Casq2−/− hearts than in Casq2+/+ hearts,3 presumably because of shorter time constant of junctional sarcoplasmic reticulum filling. Consistent with these findings, we have not observed any increase in repolarization alternans after isoproterenol administration in Casq2−/− animals.
In summary, we report several new ECG findings in Casq2−/− animals that are relevant to arrhythmogenesis in this CPVT model. They may provide new insights into arrhythmogenesis in CPVT and related conditions. Specifically, non-alternans RL has been associated with arrhythmias in the setting of impaired repolarization, but has not been previously reported in CPVT. Non-alternans RL has also been reported in human subjects prior to spontaneous VT onset20 and in the setting of canine myocardial ischemia.35 It is therefore possible that it might be a more general marker of arrhythmic propensity, and merits further study.
Limitations
Although this model provides important insights into human CPVT, murine cardiac physiology is sufficiently different from that of large mammals that some of the findings may not be relevant clinically. Increased RL has been linked to arrhythmias in other settings, but at this time, there is no firm evidence that the phenomena described in this paper are causally related to arrhythmogenesis in Casq2−/− mice.
Conclusion
Accelerated JR, likely caused by triggered activity in His/Purkinje system, occurs frequently in Casq2−/− mice. HR acceleration precedes onset of JR and VT or complex ventricular ectopy in these animals. Absence of CASQ2 increases RL. Further increase of RL occurs prior to VT or complex ventricular ectopy onset both in unrestrained mice and after isoproterenol administration, but the alternans component of RL remains unchanged. The association between non-alternans RL and ventricular arrhythmias may be more general than previously appreciated. The possible mechanistic link between RL and arrhythmogenesis merits further study.
Acknowledgments
This work was supported in part by the US National Institutes of Health grants HL88635 and HL71670 (to B.C.K) and by the American Heart Association Established Investigator Award 0840071N (to B.C.K).
Footnotes
Dr. Nemec is co-owner of a patent relevant to this topic. Dr. Shusterman is co-inventor of patents, owned by the University of Pittsburgh, relevant to this topic. Other authors: No disclosures.
HR in beats per minute and RR interval in ms are related by the formula RR = 60,000/HR. Longer RR interval is synonymous with slower HR.
All RL calculated in this paper are negative, because signal labiolity is always substantially smaller than QRS amplitude. RL value of, for example, −3.5, indicates gigher repolarization lability than −4.5.
References
- 1.Chopra N, Knollmann BC. Cardiac calsequestrin: the new kid on the block in arrhythmias. J Cardiovasc Electrophysiol. 2009;20:1179–1185. doi: 10.1111/j.1540-8167.2009.01531.x. [DOI] [PubMed] [Google Scholar]
- 2.Gyorke S, Stevens SC, Terentyev D. Cardiac calsequestrin: quest inside the SR. J Physiol. 2009;587:3091–3094. doi: 10.1113/jphysiol.2009.172049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kornyeyev D, Petrosky AD, Zepeda B, Ferreiro M, Knollmann B, Escobar AL. Calsequestrin 2 deletion shortens the refractoriness of Ca(2+) release and reduces rate-dependent Ca(2+)-alternans in intact mouse hearts. J Mol Cell Cardiol. 2012;52:21–31. doi: 10.1016/j.yjmcc.2011.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Qin J, Valle G, Nani A, Nori A, Rizzi N, Priori SG, Volpe P, Fill M. Luminal Ca2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants. J Gen Physiol. 2008;131:325–334. doi: 10.1085/jgp.200709907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Terentyev D, Kubalova Z, Valle G, Nori A, Vedamoorthyrao S, Terentyeva R, Viatchenko-Karpinski S, Bers DM, Williams SC, Volpe P, Gyorke S. Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death. Biophys J. 2008;95:2037–2048. doi: 10.1529/biophysj.107.128249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512–1519. doi: 10.1161/01.cir.91.5.1512. [DOI] [PubMed] [Google Scholar]
- 7.Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, Donarum EA, Marino M, Tiso N, Viitasalo M, Toivonen L, Stephan DA, Kontula K. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001;103:485–490. doi: 10.1161/01.cir.103.4.485. [DOI] [PubMed] [Google Scholar]
- 8.Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196–200. doi: 10.1161/01.cir.103.2.196. [DOI] [PubMed] [Google Scholar]
- 9.Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, Levy-Nissenbaum E, Khoury A, Lorber A, Goldman B, Lancet D, Eldar M. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet. 2001;69:1378–1384. doi: 10.1086/324565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Postma AV, Denjoy I, Hoorntje TM, Lupoglazoff JM, Da Costa A, Sebillon P, Mannens MM, Wilde AA, Guicheney P. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2002;91:e21–26. doi: 10.1161/01.res.0000038886.18992.6b. [DOI] [PubMed] [Google Scholar]
- 11.Knollmann BC, Chopra N, Hlaing T, Akin B, Yang T, Ettensohn K, Knollmann BE, Horton KD, Weissman NJ, Holinstat I, Zhang W, Roden DM, Jones LR, Franzini-Armstrong C, Pfeifer K. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2006;116:2510–2520. doi: 10.1172/JCI29128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Song L, Alcalai R, Arad M, Wolf CM, Toka O, Conner DA, Berul CI, Eldar M, Seidman CE, Seidman JG. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2007;117:1814–1823. doi: 10.1172/JCI31080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994;330:235–241. doi: 10.1056/NEJM199401273300402. [DOI] [PubMed] [Google Scholar]
- 14.Cantillon DJ, Stein KM, Markowitz SM, Mittal S, Shah BK, Morin DP, Zacks ES, Janik M, Ageno S, Mauer AC, Lerman BB, Iwai S. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. J Am Coll Cardiol. 2007;50:166–173. doi: 10.1016/j.jacc.2007.02.069. [DOI] [PubMed] [Google Scholar]
- 15.Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH, 2nd, Sethuraman B, Dettmer MM, Rosenbaum DS. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol. 2009;53:471–479. doi: 10.1016/j.jacc.2008.08.077. [DOI] [PubMed] [Google Scholar]
- 16.Atiga WL, Calkins H, Lawrence JH, Tomaselli GF, Smith JM, Berger RD. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol. 1998;9:899–908. doi: 10.1111/j.1540-8167.1998.tb00130.x. [DOI] [PubMed] [Google Scholar]
- 17.Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol. 2004;44:1481–1487. doi: 10.1016/j.jacc.2004.06.063. [DOI] [PubMed] [Google Scholar]
- 18.Nemec J, Hejlik JB, Shen WK, Ackerman MJ. Catecholamine-induced T-wave lability in congenital long QT syndrome: a novel phenomenon associated with syncope and cardiac arrest. Mayo Clin Proc. 2003;78:40–50. doi: 10.4065/78.1.40. [DOI] [PubMed] [Google Scholar]
- 19.Nemec J, Kim JJ, Gabris B, Salama G. Calcium oscillations and T-wave lability precede ventricular arrhythmias in acquired long QT type 2. Heart Rhythm. 2010;7:1686–1694. doi: 10.1016/j.hrthm.2010.06.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Shusterman V, Goldberg A, London B. Upsurge in T-wave alternans and nonalternating repolarization instability precedes spontaneous initiation of ventricular tachyarrhythmias in humans. Circulation. 2006;113:2880–2887. doi: 10.1161/CIRCULATIONAHA.105.607895. [DOI] [PubMed] [Google Scholar]
- 21.Thomsen MB, Verduyn SC, Stengl M, Beekman JD, de Pater G, van Opstal J, Volders PG, Vos MA. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Circulation. 2004;110:2453–2459. doi: 10.1161/01.CIR.0000145162.64183.C8. [DOI] [PubMed] [Google Scholar]
- 22.Verrier RL, Klingenheben T, Malik M, El-Sherif N, Exner DV, Hohnloser SH, Ikeda T, Martinez JP, Narayan SM, Nieminen T, Rosenbaum DS. Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol. 2011;58:1309–1324. doi: 10.1016/j.jacc.2011.06.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Chudin E, Goldhaber J, Garfinkel A, Weiss J, Kogan B. Intracellular Ca(2+) dynamics and the stability of ventricular tachycardia. Biophys J. 1999;77:2930–2941. doi: 10.1016/S0006-3495(99)77126-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Diaz ME, O’Neill SC, Eisner DA. Sarcoplasmic reticulum calcium content fluctuation is the key to cardiac alternans. Circ Res. 2004;94:650–656. doi: 10.1161/01.RES.0000119923.64774.72. [DOI] [PubMed] [Google Scholar]
- 25.Walker ML, Wan X, Kirsch GE, Rosenbaum DS. Hysteresis effect implicates calcium cycling as a mechanism of repolarization alternans. Circulation. 2003;108:2704–2709. doi: 10.1161/01.CIR.0000093276.10885.5B. [DOI] [PubMed] [Google Scholar]
- 26.Liu GX, Choi BR, Ziv O, Li W, de Lange E, Qu Z, Koren G. Differential Conditions for Early After depolarizations and Triggered Activity in Cardiomyocytes Derived from Transgenic LQT1 and LQT2 rabbits. J Physiol. 2011 doi: 10.1113/jphysiol.2011.218164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Vinogradova TM, Zhou YY, Maltsev V, Lyashkov A, Stern M, Lakatta EG. Rhythmic ryanodine receptor Ca2+ releases during diastolic depolarization of sinoatrial pacemaker cells do not require membrane depolarization. Circ Res. 2004;94:802–809. doi: 10.1161/01.RES.0000122045.55331.0F. [DOI] [PubMed] [Google Scholar]
- 28.Hilliard FA, Steele DS, Laver D, Yang Z, Le Marchand SJ, Chopra N, Piston DW, Huke S, Knollmann BC. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. J Mol Cell Cardiol. 2010;48:293–301. doi: 10.1016/j.yjmcc.2009.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Galimberti ES, Knollmann BC. Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca(2+) waves in permeabilized myocytes lacking calsequestrin. J Mol Cell Cardiol. 2011;51:760–768. doi: 10.1016/j.yjmcc.2011.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Swaminathan PD, Purohit A, Soni S, Voigt N, Singh MV, Glukhov AV, Gao Z, He BJ, Luczak ED, Joiner ML, Kutschke W, Yang J, Donahue JK, Weiss RM, Grumbach IM, Ogawa M, Chen PS, Efimov I, Dobrev D, Mohler PJ, Hund TJ, Anderson ME. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest. 2011;121:3277–3288. doi: 10.1172/JCI57833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Cerrone M, Noujaim SF, Tolkacheva EG, Talkachou A, O’Connell R, Berenfeld O, Anumonwo J, Pandit SV, Vikstrom K, Napolitano C, Priori SG, Jalife J. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2007;101:1039–1048. doi: 10.1161/CIRCRESAHA.107.148064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Viitasalo M, Oikarinen L, Vaananen H, Kontula K, Toivonen L, Swan H. U-waves and T-wave peak to T-wave end intervals in patients with catecholaminergic polymorphic ventricular tachycardia, effects of beta-blockers. Heart Rhythm. 2008;5:1382–1388. doi: 10.1016/j.hrthm.2008.06.011. [DOI] [PubMed] [Google Scholar]
- 33.Nof E, Belhassen B, Arad M, Bhuiyan ZA, Antzelevitch C, Rosso R, Fogelman R, Luria D, El-Ani D, Mannens MM, Viskin S, Eldar M, Wilde AA, Glikson M. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. Heart Rhythm. 2011;8:1546–1552. doi: 10.1016/j.hrthm.2011.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Danik S, Cabo C, Chiello C, Kang S, Wit AL, Coromilas J. Correlation of repolarization of ventricular monophasic action potential with ECG in the murine heart. Am J Physiol Heart Circ Physiol. 2002;283:H372–381. doi: 10.1152/ajpheart.01091.2001. [DOI] [PubMed] [Google Scholar]
- 35.Nearing BD, Verrier RL. Progressive increases in complexity of T-wave oscillations herald ischemia-induced ventricular fibrillation. Circ Res. 2002;91:727–732. doi: 10.1161/01.res.0000038887.17976.33. [DOI] [PubMed] [Google Scholar]





